Belantamab mafodotin Antibody, CAS [[2050232-20-5]], Unconjugated

Catalog Number: BYT-ORB2279041
Article Name: Belantamab mafodotin Antibody, CAS [[2050232-20-5]], Unconjugated
Biozol Catalog Number: BYT-ORB2279041
Supplier Catalog Number: orb2279041
Alternative Catalog Number: BYT-ORB2279041-1,BYT-ORB2279041-10,BYT-ORB2279041-25,BYT-ORB2279041-5
Manufacturer: Biorbyt
Category: Biochemikalien
Conjugation: Unconjugated
Alternative Names: ADCs, AntibodyDrugConjugates(ADCs), AntibodyDrugConjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates, Belantamab mafodotin, Belantamab mafodotin-blm, GSK2857916, GSK-2857916, GSK 2857916
Belantamab mafodotin (GSK2857916) is a BCMA-targeting antibody-drug conjugate for multiple myeloma research. It promotes immune cell activity within tumors and inhibits tumor progression, making it applicable for both in vitro mechanistic studies and in vivo xenograft models of hematological malignancies.
Concentration: 7.98 mg/mL
Molecular Weight: 146.06 kDa
Purity: 99.14% (May vary between batches)
CAS Number: [2050232-20-5]
Target: Antibody-Drug Conjugates (ADCs)